screen_shot_2012-07-24_at_15

Comms agency WCG expands team

July 24, 2012
Medical Communications London, WCG, healthcare comms

WCG has announced a string of appointments whilst also being ranked twelfth among healthcare firms in PRWeek’s UK league tables. …

Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012
Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …

NICE image

NICE to assess high cost drugs for rare conditions

July 24, 2012
Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions

NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …

Microneedles image

Microneedles could transform delivery of drugs to the eye

July 24, 2012
Manufacturing and Production, Research and Development AMD, avastin, microneedles

Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using …

ABPI names new Medical, Innovation and Research director

July 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bina Rawal, Stephen Whitehead

The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …

uniQure's Glybera

EMA recommends first new gene therapy

July 24, 2012
Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure

Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …

Pharma buoys Albemarle results in second quarter

July 24, 2012
Manufacturing and Production Albemarle, manufacturing

Albemarle succumbed to pressure in the market in the second quarter as sales fell 8% to $685 million, although the …

Michael Ball

Supplier defect blamed in Hospira recall case

July 24, 2012
Manufacturing and Production FDA, Hospira, Michael Ball

Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …

Contract research news in brief

July 23, 2012
Research and Development Clinipace Worldwide, Medpace, Paraxel, Synexus, eResearch Technologies and invivodata

A round-up of recent developments in the contract research sector, including updates from Parexel, Medpace, Clinipace, Synexus and ERT.

120711-melanie-welham-300

BBSRC appoints new director of science

July 23, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BBSRC, Melanie Welham

BBSRC the government-funded bioscience research organisation has announced the appointment of Professor Melanie Welham as director of science. Welham is …

NHS image

CCGs already improving patient care

July 23, 2012
Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms

Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …

johnosborn

Onyx appoints John Osborn as senior VP

July 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx

Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …

Waggener Edstrom appoints vice president

July 20, 2012
Business Services, Medical Communications, Sales and Marketing Anna Gray, Waggener Edstrom

Comms agency Waggener Edstrom has announced that Anna Gray has been appointed to lead the agency’s UK Healthcare Practice.  Joining …

Tapentadol

Grünenthal and Vifor breach Code

July 20, 2012
Sales and Marketing ABPI, Grunenthal, PMCPA, Vifor, code, tapentadol

Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …

Humira image

Humira powers ahead as Abbott prepares split

July 19, 2012
Sales and Marketing AbbVie, Abbott, Humira, RA

Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …

marie_little

Home Digital appoints Doctors.net.uk senior head

July 19, 2012
Business Services, Medical Communications, Sales and Marketing Doctors.net.uk, Home Digital

Digital marketing agency Home Digital has hired Marie Little as the company’s commercial director. In this newly created role she …

david_milton

Senior appointments for Takeda’s Europe and Canada team

July 18, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda Pharmaceuticals has appointed David Milton as head of Marketing & Product Portfolio Strategy, and Dr Nizamul Islam as head …

New J&J chief still struggling with scandals

July 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga

Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

gsk image

GSK raises stake in Amicus for Fabry drug

July 18, 2012
Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D

GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …

The Gateway to Local Adoption Series

Latest content